CEO Paul Lang stated that the company achieved $123.5 million of adjusted EBITDA in Q1 2025 despite a soft market environment. Additionally, they returned $106.6 million to shareholders through share ...

The average one-year price target for Core Scientific (NasdaqGS:CORZ) has been revised to $25.48 / share. This is an increase of 18.52% from the prior estimate of $21.49 dated November 7, 2025. The ...

VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation ...

VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next-generation agentic ...